These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
318 related articles for article (PubMed ID: 9527930)
1. Reactivities of human sera with human herpesvirus-8-infected BCBL-1 cells and identification of HHV-8-specific proteins and glycoproteins and the encoding cDNAs. Chandran B; Smith MS; Koelle DM; Corey L; Horvat R; Goldstein E Virology; 1998 Mar; 243(1):208-17. PubMed ID: 9527930 [TBL] [Abstract][Full Text] [Related]
2. Comparison of human sera reactivities in immunoblots with recombinant human herpesvirus (HHV)-8 proteins associated with the latent (ORF73) and lytic (ORFs 65, K8.1A, and K8.1B) replicative cycles and in immunofluorescence assays with HHV-8-infected BCBL-1 cells. Zhu L; Wang R; Sweat A; Goldstein E; Horvat R; Chandran B Virology; 1999 Apr; 256(2):381-92. PubMed ID: 10191203 [TBL] [Abstract][Full Text] [Related]
3. Seroreactivity to Kaposi's sarcoma-associated herpesvirus (human herpesvirus 8) latent nuclear antigen in AIDS-associated Kaposi's sarcoma patients depends on CD4+ T-cell count. de Souza VA; Pierrotti LC; Sumita LM; Freire WS; Segurado AA; Pannuti CS J Med Virol; 2007 Oct; 79(10):1562-8. PubMed ID: 17705173 [TBL] [Abstract][Full Text] [Related]
4. Patterns of antibodies against latent and lytic antigens of human herpesvirus 8 in an endemic population and patients with Kaposi's sarcoma in Mozambique. Caterino-de-Araujo A; Magri MC; Manuel RC J Med Virol; 2010 Sep; 82(9):1576-81. PubMed ID: 20648612 [TBL] [Abstract][Full Text] [Related]
5. A comparative study of the frequency of antibody and titers against human herpesvirus 8 latent and lytic antigens in "at-risk" individuals and among patients with Kaposi's sarcoma. Magri MC; Carbone PH; de los Santos-Fortuna E; Caterino-de-Araujo A J Med Virol; 2009 Jul; 81(7):1292-7. PubMed ID: 19475629 [TBL] [Abstract][Full Text] [Related]
6. Antibody reactivity to latent and lytic antigens to human herpesvirus-8 in longitudinally followed homosexual men. Biggar RJ; Engels EA; Whitby D; Kedes DH; Goedert JJ J Infect Dis; 2003 Jan; 187(1):12-8. PubMed ID: 12508141 [TBL] [Abstract][Full Text] [Related]
7. Human herpesvirus 8 seroconversion in Kenyan women by enzyme-linked immunosorbent assay and immunofluorescence assay. Chohan BH; Taylor H; Obrigewitch R; Lavreys L; Richardson BA; Mandaliya KN; Bwayo JJ; Kreiss JK; Morrow RA J Clin Virol; 2004 Jun; 30(2):137-44. PubMed ID: 15125869 [TBL] [Abstract][Full Text] [Related]
9. Antibodies to human herpesvirus 8 latent and lytic antigens in blood donors and potential high-risk groups in Sweden: variable frequencies found in a multicenter serological study. Enbom M; Sheldon J; Lennette E; Schulz T; Ablashi DV; Neipel F; Biberfeld P; Carlberg H; Ljungman P; Nilsson A; Söderström T; Wadström J; Linde A J Med Virol; 2000 Dec; 62(4):498-504. PubMed ID: 11074479 [TBL] [Abstract][Full Text] [Related]
10. Comparison of serologic responses between Kaposi's sarcoma-positive and -negative men who were seropositive for both human herpesvirus 8 and human immunodeficiency virus. Inoue N; Spira T; Lam L; Corchero JL; Luo W J Med Virol; 2004 Oct; 74(2):202-6. PubMed ID: 15332267 [TBL] [Abstract][Full Text] [Related]
11. Identification of a major latent nuclear antigen, LNA-1, in the human herpesvirus 8 genome. Kellam P; Boshoff C; Whitby D; Matthews S; Weiss RA; Talbot SJ J Hum Virol; 1997; 1(1):19-29. PubMed ID: 10195227 [TBL] [Abstract][Full Text] [Related]
12. The seroprevalence of human herpesvirus 8 infection in the Thai population. Ayuthaya PI; Katano H; Inagi R; Auwanit W; Sata T; Kurata T; Yamanishi K Southeast Asian J Trop Med Public Health; 2002 Jun; 33(2):297-305. PubMed ID: 12236428 [TBL] [Abstract][Full Text] [Related]
13. Kaposi's sarcoma-associated herpesvirus serology in Europe and Uganda: multicentre study with multiple and novel assays. Schatz O; Monini P; Bugarini R; Neipel F; Schulz TF; Andreoni M; Erb P; Eggers M; Haas J; Buttò S; Lukwiya M; Bogner JR; Yaguboglu S; Sheldon J; Sarmati L; Goebel FD; Hintermaier R; Enders G; Regamey N; Wernli M; Stürzl M; Rezza G; Ensoli B J Med Virol; 2001 Sep; 65(1):123-32. PubMed ID: 11505454 [TBL] [Abstract][Full Text] [Related]
14. Prevalence of Kaposi's sarcoma associated herpesvirus infection measured by antibodies to recombinant capsid protein and latent immunofluorescence antigen. Simpson GR; Schulz TF; Whitby D; Cook PM; Boshoff C; Rainbow L; Howard MR; Gao SJ; Bohenzky RA; Simmonds P; Lee C; de Ruiter A; Hatzakis A; Tedder RS; Weller IV; Weiss RA; Moore PS Lancet; 1996 Oct; 348(9035):1133-8. PubMed ID: 8888167 [TBL] [Abstract][Full Text] [Related]
15. Comparison of serologic assays for detection of antibodies against human herpesvirus 8. Corchero JL; Mar EC; Spira TJ; Pellett PE; Inoue N Clin Diagn Lab Immunol; 2001 Sep; 8(5):913-21. PubMed ID: 11527803 [TBL] [Abstract][Full Text] [Related]
16. Recombinant ORF66 and ORFK12 antigens for the detection of human herpesvirus 8 antibodies in HIV-positive and -negative patients. Yang TC; Chang CP; Lan YC; Liu CL; Shih MC; Wu FY; Lin CW Biotechnol Lett; 2009 May; 31(5):629-37. PubMed ID: 19142585 [TBL] [Abstract][Full Text] [Related]
17. Expression and localization of human herpesvirus 8-encoded proteins in primary effusion lymphoma, Kaposi's sarcoma, and multicentric Castleman's disease. Katano H; Sato Y; Kurata T; Mori S; Sata T Virology; 2000 Apr; 269(2):335-44. PubMed ID: 10753712 [TBL] [Abstract][Full Text] [Related]
18. Kaposi's sarcoma-associated herpesvirus/human herpesvirus 8 infection in reactive lymphoid tissues: a model for KSHV/HHV-8-related lymphomas? Lazzi S; Bellan C; Amato T; Palummo N; Cardone C; D'Amuri A; De Luca F; Beyanga M; Facchetti F; Tosi P; Leoncini L Hum Pathol; 2006 Jan; 37(1):23-31. PubMed ID: 16360412 [TBL] [Abstract][Full Text] [Related]